期刊文献+

我院436例/次地高辛血药浓度监测结果分析 被引量:6

Analysis of the Results of 436 Cases/Times of Digoxin Serum Concentration Monitoring
原文传递
导出
摘要 目的:为临床制订个体化给药方案提供参考。方法:采用化学发光免疫分析法对我院2013年监测的436例/次地高辛血药浓度监测结果进行统计和分析。结果:患者以男性为主,占65.36%;65岁以上患者占84.17%;血药浓度在0.5-2.0 ng/ml范围的有281例,占64.45%;血药浓度〉2.0或〈0.5 ng/ml的分别占22.25%和13.30%;女性平均血药浓度高于男性,其中血药浓度〉2.0 ng/ml的女性患者占30.46%,亦高于男性患者(17.89%)。结论:地高辛血药浓度受患者年龄、性别等因素影响。血药浓度监测结果应与患者的生理、病理情况及临床表现结合,以制订个体化给药方案。 OBJECTIVE:To analyze the results of digoxin blood concentration monitoring and provide references for clinical rational drug use. METHODS:Chemiluminescence immunoassay technique was conducted to count and analyze 436 cases/times of digoxin blood concentrations monitoring results of our hospital in 2013. RESULTS:Most patients were male,accounting for65.36%,and the patients over 65 years old accounted for 84.17%. Concentration in the range of 0.5-2.0 ng/ml accounted for64.45%,22.25% were 2.0 ng/ml and 13.30% were 0.5 ng/ml. The average drug concentration of female was higher than that of male,which female patients 2.0 ng/ml accounted for 30.46%,and higher than male patients(17.89%). CONCLUSIONS:Digoxin blood concentration is influenced by age,gender and other factors. The individualized regimen should be developed on the basis of blood concentration monitoring,physiology,pathology and clinical manifestations.
出处 《中国药房》 CAS 北大核心 2015年第11期1499-1501,共3页 China Pharmacy
关键词 地高辛 性别 血药浓度监测 年龄 Digoxin Gender Blood concentration monitoring Age
  • 相关文献

参考文献12

二级参考文献63

共引文献57

同被引文献51

  • 1黄慧萍,吕慧仪.MIMS心血管疾病用药指南:2014/2015[M].10版.香港:美迪医讯亚太有限公司,2014:385-387.
  • 2Elsa-Grace Giardina,Lynne Sylvia.Treatment with digoxin:initial dosing,monitoring,and dose modification[EB/OL].[2015-05-17].https://uptodate.bidmc.org/contents/treatment-with-digoxin-initial-dosing-monitoring-and-dosemodification.
  • 3Di Domenico RJ,Bress AP,Na-Thalang K,et al.Use of a simplified nomogram to individualize digoxin dosing versus standard dosing practices in patients with heart failure[J].Pharmacotherapy,2014,34(11):1 121.
  • 4Bauman JL,Di Domenico RJ,Viana M,et al.A method of determining the dose of digoxin for heartfailure in the modern era[J].Arch Intern Med,2006,166(22):2 539.
  • 5Flory JH,Ky B,Haynes K,et al.Observational cohort study of the safety of digoxin use in women with heart failure[J].BMJ Open,2012,2(2):e000 888.
  • 6Rathore SS,Curtis JP,Wang Y,et al.Association of serum digoxin concentration and outcomes inpatients with heart failure[J].JAMA,2003,289(7):871.
  • 7Goldberger ZD,Goldberger AL.Therapeutic ranges of serum digoxin concentrations in patients with heart failure[J].Am J Cardiol,2012,109(12):1 818.
  • 8Digitalis Investigation Group.The effect of digoxin on mortality and morbidity in patients with heart failure[J].NEngl J Med,1997,336(8):525.
  • 9Guyatt GH,Sullivan MJ,Fallen EL,et al.A controlled trial of digoxin in congestive heart failure[J].Am J Cardiol,1988,61(4):371.
  • 10Jay C,Morton H,Herbert L,et al.Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure[J].JAMA,1988,259(4):539.

引证文献6

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部